Activity of Gibbilimbol Analogues Combined with Silver Nanoparticles Against Neisseria gonorrhoeae
5 affiliations
- 1Federal University of ABC , , ,
- 2University of Southampton , , ,
- 3Mansoura University , , ,
- 4Federal University of São Paulo , , ,
- 5Butantan Institute , , ,
Abstract
Neisseria gonorrhoeae is the causative agent of gonorrhea, one of the most common sexually transmitted infections globally. Due to its increasing resistance to available antibiotics, it has been classified by the World Health Organization as a high-priority pathogen for the development of new antimicrobial strategies. In this context, natural products represent a valuable source of structurally diverse bioactive compounds and continue to serve as an inspiration for antibacterial discovery. However, their clinical application is often limited by poor solubility and low bioavailability. The incorporation of nanomaterials such as silver nanoparticles (AgNPs) has emerged as a promising strategy to overcome these limitations and improve the biological performance of natural product-based systems. In this study, combinations of gibbilimbol B analogues with AgNPs were prepared and evaluated for their in vitro bactericidal activity against N. gonorrhoeae. The individual compounds exhibited moderate bactericidal activity and low cytotoxicity toward mammalian cells, whereas combinations with AgNPs enhanced antibacterial efficacy. At the tested concentrations, the combination of AgNPs with analogue 4 showed a bactericidal effect significantly greater than the combined effect expected from the individual components, supporting a synergistic interaction under this specific experimental condition. Furthermore, the individual compounds, AgNPs, and selected AgNP–gibbilimbol analogue combinations retained bactericidal activity against antimicrobial-resistant gonococcal isolates from the CDC/FDA collection. This is the first study to combine gibbilimbol analogues with AgNPs and evaluate the bactericidal activity of these mixtures, highlighting the potential of such combinations as a novel antibacterial strategy against drug-resistant N. gonorrhoeae.
Related
- Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae
- Green Synthesis of Silver Nanoparticles Using Ammoides pusilla Extract: Optimization, Characterization, and Antimicrobial Activity
- Comparative antifungal activity of plant- and microbe-mediated silver nanoparticles against Fusarium oxysporum f. sp. cubense
- Biogenic synthesis of silver nanoparticles using Prosopis farcta: a green nanotechnology approach for enhanced antimicrobial activity
- Chiral by nature: chiroptical activity in Fe3O4 magnetic nanoparticles from bacterial biomineralization
BibTeX
@article{oliveira2026activity,
title = {{Activity of Gibbilimbol Analogues Combined with Silver Nanoparticles Against Neisseria gonorrhoeae}},
author = {Larissa V. F. Oliveira and Michael M. Girgis and Fernanda F. Camilo and Andre G. Tempone and Myron Christodoulides and João Henrique G. Lago},
journal = {ACS Omega},
year = {2026},
month = oct,
doi = {10.1021/acsomega.6c06784},
url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c06784/5461844/Activity-of-Gibbilimbol-Analogues-Combined-with},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Activity of Gibbilimbol Analogues Combined with Silver Nanoparticles Against Neisseria gonorrhoeae
AU - Larissa V. F. Oliveira
AU - Michael M. Girgis
AU - Fernanda F. Camilo
AU - Andre G. Tempone
AU - Myron Christodoulides
AU - João Henrique G. Lago
PY - 2026
DA - 2026/10/31
JO - ACS Omega
DO - 10.1021/acsomega.6c06784
UR - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c06784/5461844/Activity-of-Gibbilimbol-Analogues-Combined-with
AB - Neisseria gonorrhoeae is the causative agent of gonorrhea, one of the most common sexually transmitted infections globally. Due to its increasing resistance to available antibiotics, it has been classified by the World Health Organization as a high-priority pathogen for the development of new antimicrobial strategies. In this context, natural products represent a valuable source of structurally diverse bioactive compounds and continue to serve as an inspiration for antibacterial discovery. However, their clinical application is often limited by poor solubility and low bioavailability. The incorporation of nanomaterials such as silver nanoparticles (AgNPs) has emerged as a promising strategy to overcome these limitations and improve the biological performance of natural product-based systems. In this study, combinations of gibbilimbol B analogues with AgNPs were prepared and evaluated for their in vitro bactericidal activity against N. gonorrhoeae. The individual compounds exhibited moderate bactericidal activity and low cytotoxicity toward mammalian cells, whereas combinations with AgNPs enhanced antibacterial efficacy. At the tested concentrations, the combination of AgNPs with analogue 4 showed a bactericidal effect significantly greater than the combined effect expected from the individual components, supporting a synergistic interaction under this specific experimental condition. Furthermore, the individual compounds, AgNPs, and selected AgNP–gibbilimbol analogue combinations retained bactericidal activity against antimicrobial-resistant gonococcal isolates from the CDC/FDA collection. This is the first study to combine gibbilimbol analogues with AgNPs and evaluate the bactericidal activity of these mixtures, highlighting the potential of such combinations as a novel antibacterial strategy against drug-resistant N. gonorrhoeae.
SN - 2470-1343
ER -